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Abstract
Background: Ventricular function has conventionally been characterized using indexes of systolic
(contractile) or diastolic (relaxation/stiffness) function. Systolic indexes include maximum elastance
or equivalently the end-systolic pressure volume relation and left ventricular ejection fraction.
Diastolic indexes include the time constant of isovolumic relaxation – and the end-diastolic
pressure-volume relation. Conceptualization of ventricular contraction/relaxation coupling
presents a challenge when mechanical events of the cardiac cycle are depicted in conventional
pressure, P, or volume, V, terms. Additional conceptual difficulty arises when ventricular/vascular
coupling is considered using P, V variables.
Methods: We introduce the concept of thermodynamic phase-plane, TPP, defined by the PdV and
VdP axes.
Results: TPP allows all cardiac mechanical events and their coupling to the vasculature to be
geometrically depicted and simultaneously analyzed.
Conclusion: Conventional systolic and diastolic function indexes are easily recovered and novel
indexes of contraction-relaxation coupling are discernible.
Introduction
Heart failure (HF) is a common and eventually lethal dis-
ease whose incidence is increasing in the population [1,2].
It has only recently been appreciated that in nearly half of
patients carrying the diagnosis of HF, left ventricular (LV)
contractile function as indicated by LV ejection fraction
(EF) is relatively preserved while ventricular diastolic
relaxation/stiffness function is compromised and uncou-
pled [2,3]. In other words, the contraction-relaxation cou-
pling (CRC) is abnormal.
It is established that contraction-relaxation coupling is
mediated primarily by intra and extracellular calcium
fluxes [4-6]. In the cardiomyocyte, the dominant CRC is
via the ionized Ca2+ flux cycling between the contractile
apparatus and the sarcoplasmic reticulum, SR [4,5,7]. It
has been shown that in various cardiomyopathies this
cycling is adversely affected [8,9]. Although experimental
techniques exist that characterize this uncoupling at the
cardiomyocyte level, there is a lack of both a conceptual
and an experimental framework by which this type of
uncoupling can be characterized at the whole-heart level.
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In principle, the Frank-Starling Law, which is an experi-
mentally determined relationship, should characterize
contraction-relaxation coupling. Because the Frank-Star-
ling Law is based on experimental observation, rather
than being derived from basic laws, there are no explicit
mathematical relationships defining CRC using different
contraction-relaxation indices. In this study we use a
mathematical modeling approach motivated by the his-
torical utility of P and V as variables that define ventricular
pump function; the ability of phase-plane methods to
characterize the properties of oscillators and the goal to
express the macroscopic consequences of contraction-
relaxation coupling by introduction of a new concept suit-
able for derivation of physiologic CRC indexes. The intent
is to facilitate quantification of the presence and severity
of contractile-relaxation dysfunction by the use of these
CRC indexes. We tested our preliminary concepts using
conductance catheter derived pressure-volume data from
a limited number of human subjects. Results indicate that
derived CRC indexes may differentiate between normal
and abnormal contraction-relaxation states. Further clini-
cal studies, particularly in selected pathologic subsets, are
needed to fully validate the utility of the proposed
concepts.
Methods
In proposing our conceptual approach, we assume that
analysis of ventricular contraction/relaxation in the P-V
plane not only should correlate with the CRC at the cellu-
lar level but must also obey the laws of thermodynamics.
First, we note that CRC at the cellular level is measured
using features such as the rise and decay of the Ca2+ tran-
sient. It is known that the upstroke of the Ca2+ transient
precedes the onset of tension development and starts
decaying immediately. Interestingly the Ca2+ transient is
negligible at the peak of the developed tension and is not
affected by inhibition of the net SR Ca2+ uptake by 3 mM
caffeine [10].
Second, we define a differential relationship that describes
the instantaneous power, (erg/s) as the rate of change of
energy Ê (ergs), defined as Ê = PV. In such a thermody-
namic system where the heat losses during contraction are
small and are therefore negligible, instantaneous power,
dÊ/dt, can be written as:
dÊ = VdP-PdV   (1)
where we denote the time derivatives of Ê, P and V as dÊ,
dP and dV, respectively. In expression (1) the sign of PdV
is negative because we chose the system boundary as the
LV volume at a given instant. The system loses energy by
doing external work during systole when pressure rises
and volume falls – hence the negative sign of PdV. This
differential relationship defines how the energy contained
in this system changes in accordance with the laws of ther-
modynamics. During each phase of the cardiac cycle the
change in energy can be appreciated as illustrated in Fig-
ures 1 and 2 (the numbers in italics refer to phase of the P-
V loop depicted in Figure 2): (1) isovolumic contraction
when VdP > 0 and PdV = 0; (2 to 3) early systolic ejection
when VdP > 0, and PdV < 0; (5 to 6) late systolic ejection
when VdP < 0, and PdV < 0; (7) isovolumic relaxation
when VdP < 0 and PdV = 0; (8) rapid filling when VdP < 0
initially, then becomes > 0 and PdV > 0; (9) diastasis when
VdP = PdV = 0; and (10) passive filling when PdV > 0 VdP
> 0. Because these macroscopic contraction and relaxation
processes are not adiabatic, i.e. the system looses heat and
generates external work, they are causally linked to energy
consumption at the cardiomyocyte level.
In Equation 1, the VdP term denotes the potential power
that is stored as potential energy in the contractile appara-
tus of the cardiomyocyte and in the extra-cellular connec-
tive tissue matrix and intracellularly in titin as strain
energy [11,12]. Note that VdP is uniquely different from
the conventionally used indexes to describe contractility
dP/dtmax or relaxation, dP/dtmin. This potential power is
generated by the strong interaction of the actin-myosin
complex and thus should be dependent on fiber length,
Ca2+ concentration and the Ca2+ sensitivity. The second
term in the instantaneous power expression, PdV, is the
kinetic power which accounts for shortening of the con-
tractile apparatus and is the source of external work. It is a
function of the weak interaction of the actin-myosin com-
plex. Both the potential and kinetic power production ter-
minates as Ca2+ is sequestered back into SR. Thus, it is
possible to follow the course of Ca2+ cycling by consider-
ing the magnitude and time dependence of potential and
kinetic power generated by the contractile apparatus.
Thereby we obtain an index of contraction/relaxation cou-
pling (Figure 2).
To derive physiologic indexes of systolic-diastolic cou-
pling, we review the components of the cardiac cycle using
PdV and VdP as coordinates in the thermodynamic phase
plane.
The potential power becomes maximal (1) after the onset
of contraction and before aortic valve opening (2) During
the first part of ejection the potential power decreases and
kinetic power increases until kinetic. power becomes max-
imal.  (3)  The exchange between potential and kinetic
power during phase (2) and (3) occurs at a constant rate,
κ. After phase (3) both kinetic power and potential power
decline at constant but different rates, ρ. At peak systolic
pressure (dP = 0) (4) potential power becomes zero but
the net power output from the contractile apparatus is still
positive until the phase (5)  where the contractileBioMedical Engineering OnLine 2004, 3 http://www.biomedical-engineering-online.com/content/3/1/6
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apparatus is incapable of delivering any further power. At
aortic valve closure, the kinetic power becomes zero and
the potential power becomes negative (6). The potential
power decreases to a minimum at peak negative dP and
then increases again (7). At mitral valve opening, the
Doppler E-wave is inscribed (8) when kinetic power is
positive, followed by diastasis (9). Diastasis is the only
point, where both the potential power and the kinetic
power (dP = dV = 0) simultaneously become zero during
the cardiac cycle. This is followed by atrial contraction, the
Doppler A-wave, when both potential and kinetic power
is positive and the cycle repeats itself (10).
Figure 2 provides a geometric perspective of the method
of CRC index derivation. Specifically the angles κ, ρ and δ
define the contraction, relaxation and contraction/relaxa-
tion coupling behavior of a given ventricle, respectively.
These angles in the TPP provide information about the
intensity and duration of peaking and decaying of the
Ca2+  transient, respectively. Therefore the mapping of
Ca2+ transient to the TPP is important. Accordingly, nearly
the entire Ca2+ transient maps to points (1) to (7) in Fig-
ure 2.
One of the unique aspects of thermodynamic phase plane
analysis is that it depicts contraction and relaxation events
simultaneously and includes the way they are coupled. In
this phase plane, load dependence is easy to specify. We
propose that the parameters κ, ρ and δ define the contrac-
tion, relaxation and coupling properties of a given ventri-
cle. From this definition it follows that changes in (a)
preload will alter the peak potential power, peak kinetic
power but will not affect the angles κ, ρ and δ; (b) after-
load will alter the potential power at the peak kinetic
power without changes in κ, ρ and δ; (c) LV contractile
properties will alter only κ; (d) LV relaxation properties
will alter only ρ; and (e) contraction/relaxation coupling
will alter the angle δ. Note also that κ, ρ and δ are inher-
ently independent of the LV mass because these indexes
describe the ratio of the instantaneous potential to kinetic
power, which may be dependent on the LV mass.
Depiction of the cardiac cycle, including contraction/
relaxation cycling using these expressions of power in the
TPP, makes it possible to better understand the physical
and thermodynamic meaning of some contractility
indexes used widely in the past.
External Power Normalized to V2
Consider the maximal external power normalized to the
volume squared, (PdV)max/ V2  [13]. Note that during
phase (2) and (3) the kinetic power and potential power
are linearly related, hence one can write PdV = κ VdP + bκ
(Figure 2). Because (dP/V)max has been shown to be an
index of ventricular contractility [14], it follows that
The cardiac cycle in thermodynamic space Figure 1
The cardiac cycle in thermodynamic space. Vertical lines 
depict the beginning and end of systole (end systolic 
elastance), respectively.
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(PdV)max/ V2 ≈κ  (dP/V)max + bκ / V2   (2)
This novel finding indicates that previously obtained
empirical findings have a solid, and deeper thermody-
namic foundation.
Maximal elastance
End-systolic elastance had been shown to be the maximal
elastance that the ventricle can attain [15]. But, a deeper
thermodynamic explanation for this behavior has been
lacking. Noting that instantaneous elastance, E(t), is
defined as P(t)/(V(t)-Vo), the maximum of this function,
Emax, occurs when dE(t) = (V-Vo)dP-PdV = 0, or without
loss of generality i.e. by a change of variable (V-Vo) → V,
or by assuming the ventricular slack volume, Vo, is small
and is therefore negligible:
VdP = PdV   (3)
This indicates that the Emax point is defined not only
mechanistically as the maximal stiffness but also thermo-
dynamically as the point when kinetic and potential pow-
ers are equal such that the left ventricular total
thermodynamic power output is zero. This novel conse-
quence of our approach has not been previously
appreciated.
Time constant of isovolumic relaxation, τ
It is interesting to note that during isovolumic relaxation
[16] the index characterizing the relationship between dP
and P, is referred to as the 'time-constant of isovolumic relax-
ation', [17]. Noting in Figure 2 that after the maximal
kinetic power (3) and before aortic valve closure (6) one
can write
The cardiac cycle depicted in the thermodynamic phase plane Figure 2
The cardiac cycle depicted in the thermodynamic phase plane. Arrows indicate the direction of time from the onset of systole.
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PdV = ρ VdP + bρ and dV/ V constant. Because dP/P ≈ -1/τ
then
τ≈  - ρ   (4)
This linear relationship between ρ and τ suggests that τ is
a rate constant depicting the proportional decrease of
both potential and kinetic power.
Subjects and study protocol
Subjects
After obtaining informed consent, in accordance with
Washington University Medical Center Human Studies
committee criteria, we recruited 18 subjects (aged 42–73
years) from referrals scheduled for elective cardiac cathe-
terization for clinical reasons at the request of the referring
cardiologist. Subjects were enrolled if they met the follow-
ing criteria: (i) scheduled for elective left or right/left heart
catheterization, in a fasting, non-sedated state, (ii) judged
to be clinically stable (iii) willing to participate and able
to give informed consent, (iv) have no mitral valve dis-
ease, atrial fibrillation, or permanent pacemakers. Clinical
status at enrollment was recorded. Subjects were divided
into three groups: (i) normal group (n = 6) (τ < 50 ms;
LVEF > 60% and LVEDP < 12 mmHg); (ii) impaired relax-
ation group (n = 6) with normal or mildly reduced left
ventricular systolic function (EF > 50%) and evidence of
abnormal left ventricular relaxation (τ > 50 ms) and
diastolic distensibility (LVEDP > 16 mmHg) [18] and (iii)
heart failure group (n = 6) (τ > 50 ms; LVEF < 45% and
LVEDP > 16 mmHg).
Pressure volume loops were recorded using a 6F, 10-elec-
trode pressure-volume conductance pigtail catheter (Mil-
lar Instruments, Dallas, TX). Briefly, using 62 cm 6F
femoral arterial sheath (Arrow, San Leandro CA) the con-
ductance catheter was advanced through the sheath into
the central aorta, and then advanced retrogradely across
the aortic valve with the pigtail tip positioned near the left
ventricular apex. The conductance catheter was used with
a simulator-microprocessor unit (Leycom Sigma-5, Cardi-
oDynamics, Rijnsburg, The Netherlands) in dual-field
stimulation mode. Pressure-volume loops were displayed
on a personal computer to allow on-line signal acquisi-
tion and real-time display. The pressure and volume data
was digitized on-line at a rate of 200 Hz and was stored on
a computer hard disk for subsequent off-line analysis. The
baseline conductance volume data was calibrated using
ventriculogram-derived end-diastolic and end-systolic
volumes [19].
From P-V data obtained according to the above criteria,
we determined if the three groups were distinguishable
using thermodynamic phase plane analysis derived
indexes. Hence, we calculated τ, chamber contractility
using end-systolic elastance, Ees, and integrated ventricu-
lar function using the slope of preload-recruitable stroke
work relationship, Msw. All analyses were performed off-
line in the Cardiovascular Biophysics Laboratory. Pres-
sure-volume loops were analyzed for derivation of con-
tractile-relaxation indexes using a custom written software
in Visual Basic. The angles κ and ρ were estimated using
the best linear relationship between VdPmax and PdVmax
Table 1: Patient Characteristics. a = p < 0.05, b = p < 0.01 Impaired Relaxation vs Normal, d = p < 0.01 Heart Failure vs Normal, e = p < 
0.05, f = p < 0.01 Heart Failure vs Impaired Relaxation.
Normal Impaired Relaxation Heart Failure
Age years 53.5 ± 7.6 61.3 ± 7.8 59 ± 6.6
Sex 4M 2F 3M 3F 4M 2F
EF percent 68.8 ± 8. 6 69.5 ± 7.8 37.5 ± 6.4d,f
LVEDP mmHg 7.0 ± 3.0 17.5 ± 1.4b 22.4 ± 8.7d
τ ms 41.9 ± 5.2 73.4 ± 14.3b 86.3 ± 25.6d
ESV ml 41.0 ± 15.7 51.5 ± 15.7 139.5 ± 30.7d,f
EDV ml 129.9 ± 34.3 173.0 ± 48.9 223.7 ± 46.8d
Ees mmHg/ml 3.5 ± 1.8 2.93 ± 0.9 0.96 ± 0.3d,e
Msw mmHg 0.87 ± 0.19 0.89 ± 0.20 0.39 ± 0.18d,f
dP/dtmax mmHg/s 1207 ± 124 1102 ± 129 1070 ± 185
dP/dtmin mmHg/s -1536 ± 193 -1256 ± 78a -1095 ± 204d
Hr beats/min 73.9 ± 7.1 61.7 ± 8.6 71.3 ± 12.5
SP mmHg 129.5 ± 18.6 151.2 ± 28.0 135.3 ± 20.3
DP mmHg 67.7 ± 6.7 79.4 ± 10.5a 80.7 ± 8.8BioMedical Engineering OnLine 2004, 3 http://www.biomedical-engineering-online.com/content/3/1/6
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and PdVmax and VdPmin, respectively. The angle δ was cal-
culated geometrically by considering δ = κ + ρ. Data were
analyzed using ANOVA followed by Student-Newman-
Keuls multiple comparison post significance test using a
commercially available software (Instat, Graphpad). Data
are expressed as mean ± SD. and p < 0.05 level was con-
sidered statistically significant.
Results
As expected from the inclusion criteria, other differences
in these study groups were present (Table 1). Despite con-
tractility indexes similar to the normal group, the
impaired relaxation group had lower heart rates, higher
blood pressure and decreased dP/dtmin. The heart failure
group had lower contractility and relaxation indexes.
Figure 3 depicts the overall relationship between the
diastolic power conversion ratio ρ and the isovolumic
time constant, τ. As predicted by Equation 4, there was
good correlation between ρ and τ. Note that τ was calcu-
lated during the isovolumic relaxation period while ρ was
calculated during the ejection period. This finding, which
confirms prediction (d), also provides strong evidence
that ventricular relaxation begins not at the end of ejec-
tion but immediately after peak ejection [20].
As predicted by Equation 2, there was a close relationship
between the systolic power conversion ratio κ and con-
tractility indexes, Msw and Ees (Figure 4).
Figure 5 depicts pressure-volume loops and thermody-
namic phase plane analysis for a representative subject
from each group. The normal and the impaired relaxation
group had similar values for κ, ρ, δ and potential power at
end ejection (Table 2). In contrast, the heart failure group
had a higher κ and lower potential power at end ejection
but similar ρ and δ. This finding confirms predictions (a),
(b) and (c) and suggests that in this select group of heart
failure patients, not only the power generation capacity of
the ventricle is diminished but also the potential to kinetic
power conversion rate, κ.
Discussion
It is well known that the contractile and relaxation per-
formance of the left ventricle is coupled in healthy sub-
jects through the Frank-Starling mechanism. Accordingly,
altered contractile performance is met by altered relaxa-
tion properties of the ventricle causing rapid adaptation
(within one beat) to changes in demand. It is accepted
that this behavior is not a result of how the ventricle itself
is geometrically constructed but an attribute intrinsic to
the Ca2+ cycling and contractile apparatus within the car-
diomyocytes [5,21] themselves. Through increased
sensitivity of actin-myosin interaction to calcium and
through the SR Ca2+  fluxes, the contractile force and
period of relaxation is modulated. This form of contrac-
tion-relaxation coupling at the cellular level is essential for
normal function at the whole heart level. There is evi-
dence that in dilated cardiomyopathy and ischemic
cardiomyopathy contraction-relaxation coupling is
altered at the cellular level [9]. In the former case, there are
adverse changes in the Ca2+ flux from the SR leading to
slower shortening velocity. In the latter case the speed of
Ca2+  re-uptake into SR is reduced causing delayed
relaxation. Changes in Ca2+ sensitivity of the actin-myosin
interaction, on the other hand, alters the speed and extent
of both the contraction and relaxation events, thus pre-
serving the contraction-relaxation coupling [8].
Whether all aspects of normal contraction-relaxation cou-
pling are preserved at the organ level in these two and
other forms of HF such as cardiomyopathy is unknown.
Existing experimental methods do not allow observation
of in vivo Ca2+ fluxes in humans, thus only approximate
inferences using gross macroscopic mechanical behavior
can be made. In the systolic failure model for example,
diastolic performance is somewhat preserved through uti-
lization of full Frank-Starling mechanism [22]. The con-
verse may not be true. For example in long standing
hypertension where contractile function is preserved (EF >
50%) through hypertrophic remodeling, an increased
The relationship between diastolic power conversion ratio,  ρ, and isovolumic time constant τ, r2 = 0.27, p < 0.05 Figure 3
The relationship between diastolic power conversion ratio, 
ρ, and isovolumic time constant τ, r2 = 0.27, p < 0.05
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The relationship between systolic power conversion ratio, κ, and contractility indexes: (Left) Msw, r2 = 0.28, p < 0.01 Figure 4
The relationship between systolic power conversion ratio, κ, and contractility indexes: (Left) Msw, r2 = 0.51, p < 0.001, (Right) 
Ees, r2 = 0.28, p < 0.01
Typical pressure-volume loops (left), thermodynamic phase-plane plots (middle) and (right) best linear fits for the TPP plots  from normal, impaired relaxation and heart failure subjects Figure 5
Typical pressure-volume loops (left), thermodynamic phase-plane plots (middle) and (right) best linear fits for the TPP plots 
from normal, impaired relaxation and heart failure subjects.
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incidence of diastolic failure has been observed particu-
larly in elderly women [23]. This dichotomy suggests that
contraction-relaxation abnormalities associated with
remodeling may be a dominant feature in the latter case.
Unfortunately, at the organ level the mechanisms that
may account for this uncoupling of systolic and diastolic
function are not well understood. The derivation and in-
vivo validation of indexes that are specific and sensitive to
contraction-relaxation coupling at the organ level will
help elucidate and characterize the state of coupling.
Established indexes of contraction(systole) and of 
relaxation(diastole) in the left ventricle
Apart from the gross anatomical features such as the large-
scale fiber direction and orientation [24], the left ventricle
can be thought of as an assembly of cardiomyocytes that
are arranged and work in parallel and in series. It is there-
fore reasonable to assume that the simplest model for left
ventricle entails the main features of the cardiomyocyte
itself. Similar to models (Maxwell, Voigt) of the single car-
diomyocyte [25], various simplified approximations and
parameters have also been developed to quantify cardiac
mechanical events. Contraction indexes include: ejection
fraction, the time-varying elastance [15]; maximal rate of
rise of pressure [14], maximal external power [13]; and
preload recruitable stroke work [14]. Diastolic function
indexes include: the isovolumic relaxation time constant,
τ, for ventricular relaxation [17], end-diastolic pressure-
volume relationship for passive left ventricular properties
[26], conventional E-and A-wave derived indexes [27] and
the parameterized diastolic filling, (PDF), formalism
derived indexes of ventricular filling [28,29]
Despite the success of these conceptual and experimental
descriptions of distinct phases of the cardiac cycle, a defi-
ciency exists in that a comprehensive description applica-
ble to the entire cardiac cycle is absent. Specifically, these
paradigms and indexes were not specifically intended for
deriving indexes of contraction-relaxation coupling in the
intact left ventricle.
Existing indexes of contraction and relaxation coupling
The two gold standard indexes that independently
describe left ventricular contraction and relaxation prop-
erties respectively, are the end-systolic elastance, Ees, and
the isovolumic relaxation time constant, τ. Although scant
animal data indicates that Ees and  τ may be inversely
related [30], the data do not explain why it is possible to
have preserved contractile (systolic) function with con-
comitant relaxation (diastolic) dysfunction. It is also
known that Ees is relatively load-independent but τ is sen-
sitive to the timing and the amplitude of the imposed
load. Early systolic load decreases τ but late systolic load
increases τ [20]. Increased afterload initially decreases τ
but if the systolic pressure reaches 80% of isovolumic
maximum pressure, τ is increased [20,30]. Whether the
reported load sensitivity of τ is caused by methodological
details [32,33] remains an issue. Other relationships
should exist. Starting from a time-varying compliance
concept Palladino et al also derived energy-exchange
equations between the biochemical processes, mechanical
work, potential energy and heat during contraction with
considerable success [34]. We have previously shown that
SW and dP-P phase plane areas and dPmin and dPmax are
correlated [16]. This former finding constitutes prelimi-
nary data to support the concept that a coupling between
the dP-P limit cycle area generated by each cardiac cycle
and EDV exists because SW is related to EDV through
PRSWR. This state of affairs underscores the need for bet-
ter indexes by which contraction-relaxation coupling can
be quantified.
Limitations
Movement and positioning uncertainties of the conduct-
ance catheter introduces noise into the data. We have
found that this could be addressed in part by recording
longer periods, (30 seconds), of continuous data while
the hemodynamics are in steady state. Beat averaging of
data eliminates most of the movement and respiratory
artifacts. Although the derivatives of conductance signals
amplify noise, this does not adversely affect our TPP anal-
ysis because: (a) we average data for 10–16 beats, (b) con-
ductance signals are usually free from artifacts between
Table 2: TPP parameters calculated. a = p < 0.05, b = p < 0.01 Heart Failure vs Normal, c = p < 0.01 Heart Failure vs Impaired Relaxation
Normal Impaired Relaxation Heart Failure
κ degrees 50.8 ± 11.7 56.4 ± 12.0 69.6 ± 7.8a
bκ (×103) mmHg.ml/s 108.4 ± 51.3 148.0 ± 90.9 188.0 ± 35.9
ρ degrees -25.9 ± 8.5 -22.5 ± 9.9 -14.6 ± 10.4
bρ (×103) mmHg.ml/s -13.5 ± 3.8 -10.4 ± 4.2 12.1 ± 6.2b,c
δ degrees 76.6 ± 15.7 78.8 ± 13.5 89.8 ± 9.1BioMedical Engineering OnLine 2004, 3 http://www.biomedical-engineering-online.com/content/3/1/6
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phases (2) and (6) (Figure 5), and (c) because the way the
VdP and PdV are depicted in TPP analysis, the impact of
noise due to derivatives is reduced.
Based on the inclusion criteria, we considered a high EF,
increased LVEDP and increased τ would suffice to classify
the impaired relaxation group. Because passive diastolic
properties of the LV chamber also contributes to the
LVEDP, the discrimination between the normal and
impaired relaxation group may not be powerful. Other
factors which directly affect P and V, such as underlying
pathology, heart rate, medications, preload, contractility
and afterload could modulate the CRC indexes. We have,
however, found a significant correlation between τ and ρ
suggesting active relaxation processes are indeed reflected
in ρ. Our analysis suggests that in this select group of
subjects the magnitude of relaxation impairment was not
sufficient to be detectable, although a trend suggesting
that ρ was lower was present. Further studies, involving
larger number of subjects with documented diastolic
heart failure will be carried out to determine if this trend
is significant.
Conclusion
The proposed thermodynamic phase plane analysis
method presented forms the basis of an evolving concep-
tual approach for quantitative contraction-relaxation
assessment. Additional work in well-defined clinical
pathophysiologic subsets as well as experimental animal
models will aid in defining its full potential. Utilization in
the aforementioned settings will facilitate complete deter-
mination of the relationship between current ventricular
systolic and diastolic function assessment methods and
the thermodynamic phase plane analysis method.
Although our work is preliminary, and in a modest
number of subjects, we found that the thermodynamic
phase plane analysis method can not only quantitatively
characterize the standard clinical systolic and diastolic
ventricular function indexes but is able to elucidate their
deeper thermodynamic basis. Our results justify further
studies in order to extend these findings to subjects and
animal models with and without impaired contraction/
relaxation states due to various clinical (diabetes, hyper-
tension, obesity etc) and specific molecular-cellular
(titionopathies, myosinopathies, etc) etiologies.
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